Literature DB >> 7781446

Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome.

G Cadiot1, C Vissuzaine, F Potet, M Mignon.   

Abstract

In the Zollinger-Ellison syndrome, fundic argyrophil carcinoid tumors occur almost exclusively in the small subgroup of patients who also have multiple endocrine neoplasia type 1. In these patients, tumor development seems related to the same genetic alterations as those observed in other endocrine tumors related to multiple endocrine neoplasia type 1. We report here the second detailed case of a patient with sporadic Zollinger-Ellison syndrome who developed an argyrophil carcinoid tumor in nonatrophic fundic mucosa, suggesting that chronic hypergastrinemia may lead to fundic carcinoid development in nongenetically predisposed patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781446     DOI: 10.1007/bf02065537

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

Review 1.  Histopathological classification of nonantral gastric endocrine growths in man.

Authors:  E Solcia; C Bordi; W Creutzfeldt; Y Dayal; A D Dayan; S Falkmer; L Grimelius; N Havu
Journal:  Digestion       Date:  1988       Impact factor: 3.216

2.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

Review 3.  Diagnosis and treatment of Zollinger-Ellison syndrome.

Authors:  M Mignon; S Bonfils
Journal:  Baillieres Clin Gastroenterol       Date:  1988-07

4.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

Authors:  E Friedman; K Sakaguchi; A E Bale; A Falchetti; E Streeten; M B Zimering; L S Weinstein; W O McBride; Y Nakamura; M L Brandi
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

5.  Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?

Authors:  G Cadiot; P Laurent-Puig; B Thuille; T Lehy; M Mignon; S Olschwang
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

6.  Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.

Authors:  G E Feurle
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.

Authors:  T Lehy; G Cadiot; M Mignon; P Ruszniewski; S Bonfils
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

8.  Toxicological studies on omeprazole.

Authors:  L Ekman; E Hansson; N Havu; E Carlsson; C Lundberg
Journal:  Scand J Gastroenterol Suppl       Date:  1985

9.  Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis.

Authors:  D Cattan; A M Roucayrol; J M Launay; J Callebert; N Charasz; Y Nurit; J Belaiche; R Kalifat
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

10.  Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats.

Authors:  Y Tielemans; R Håkanson; F Sundler; G Willems
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

View more
  15 in total

1.  Hypergastrinaemia in patients infected with Helicobacter pylori treated with proton pump inhibitors.

Authors:  H L Waldum
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 2.  Antiulcer drugs and gastric cancer.

Authors:  Helge L Waldum; Bjørn Gustafsson; Reidar Fossmark; Gunnar Qvigstad
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Development of an inveterate gastroduodenal ulcer caused by antral G-cell hyperplasia of the stomach (pseudo-Zollinger-Ellison Syndrome): report of a case.

Authors:  S Takeno; T Noguchi; N Kubo; T Sato; Y Uchida; A Moriuchi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 4.  Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.

Authors:  Jeffrey A Norton; Robert T Jensen
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

Review 5.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 6.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 7.  Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Martin Anlauf; Aurel Perren
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

Review 8.  Diagnosis and treatment of ECL cell tumors.

Authors:  G Cadiot; D Cattan; M Mignon
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 9.  Pathogenesis of ECL cell tumors in humans.

Authors:  C Bordi; T D'Adda; C Azzoni; G Ferraro
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 10.  Gastritis, Gastric Polyps and Gastric Cancer.

Authors:  Helge Waldum; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.